'Rare cancers': not all together in clinical studies!

Casali, P G; Licitra, L; Frezza, A M; Trama, A

Casali, P G; Licitra, L; Frezza, A M; Trama, A.

Afiliación

Casali PG; Medical Oncology Unit 2, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Oncology and Haemato-Oncology Department, University of Milan, Milan, Italy. Electronic address: paolo.casali@istitutotumori.mi.it.
Licitra L; Medical Oncology Unit 3, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Oncology and Haemato-Oncology Department, University of Milan, Milan, Italy. Electronic address: https://twitter.com/annamariafrezza.
Frezza AM; Medical Oncology Unit 2, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: https://twitter.com/licitra_lisa.
Trama A; Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Ann Oncol ; 33(5): 463-465, 2022 05.

Article en En | MEDLINE | ID: mdl-35131451

Asunto(s)

Neoplasias; Humanos; Neoplasias/terapia; Enfermedades Raras

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google